Skip to main content
NCBI home page
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1975 Feb;55(2):224–229. doi: 10.1172/JCI107925

Propylthiouracil blocks extrathyroidal conversion of thyroxine to triiodothyronine and augments thyrotropin secretion in man.

D L Geffner, M Azukizawa, J M Hershman
PMCID: PMC301740  PMID: 805160

Abstract

Propylthiouracil (PTU) inhibits peripheral deiodination of thyroxine (T4) and triiodothyronine (T3) and decreases the metabolic effectiveness of T4 in animals. To assess the effect of PTU on extrathyroidal conversion of T4 to T3 in man, 15 studies were performed in athyreotic patients treated with 100 or 200 mug of L-T4 daily for 1 mo before the addition of PTU, 250 mg every 6 h for 8 days. serum T3, T4, and thyrotropin (TSH) were measured daily by radioimmunoassay; serum TSH response to 500-mug thyrotropin-releasing hormone (TRH) was measured before and on the last day of giving PTU. On the 100-mug LT4 dose, serum T3 fell from 120 plus or minus 5 (SE) to 83 plus or minus 6 ng/dl (P less than 0.005) with return to 113 plus or minus 5 ng/dl after stopping PTU; serum T4 (4.5 plus or minus 0.3 mug/dl) did not change. Similar results were seen in patients taking 200 mug of L-T4 daily. On the 100-mug dose of L-T4 the fall in T3 was accompanied by a reciprocal rise in serum TSH to 195 plus or minus 33% of initial concentration (P less than 0.01) with return to 104 plus or minus 8% after PTU. The serum TSH response to TRH (DELTAMUU/ml over base line) was greater during PTU therapy than during the control period. On 100-mug L-T4 DELTA TSH rose from 64 plus or minus 19 to 101 plus or minus 23 muU/ml (P less than 0.005). Expressed as percent of base-line TSH concentration, TSH rose from 140 plus or minus 52 to 280 plus or minus 44% (control vs. PTU) at 15 min, 265 plus or minus 72 to 367 plus or minus 63% at 30 min, 223 plus or minus 54 to 313 plus or minus 54% at 45 min, 187 plus or minus 45 to 287 plus or minus 51% at 60 min, and 145 plus or minus 22 to 210 plus or minus 28% at 120 min after TRH. The data suggest that PTU blocks extrathyroidal conversion of T4 to T3, thus increasing pituitary TSH secretion and augmenting the TSH response to TRH.

Full text

PDF
224

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Abuid J., Larsen P. R. Triiodothyronine and thyroxine in hyperthyroidism. Comparison of the acute changes during therapy with antithyroid agents. J Clin Invest. 1974 Jul;54(1):201–208. doi: 10.1172/JCI107744. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. BARKER S. B., KIELY C. E., Jr, LIPNER H. J. Metabolic effects of thyroxine injected into normal, thiouracil-treated and thyroidectomized rats. Endocrinology. 1949 Dec;45(6):624–627. doi: 10.1210/endo-45-6-624. [DOI] [PubMed] [Google Scholar]
  3. BRAVERMAN L. E., INGBAR S. H. Effects of propylthiouracil and thiouracil on the metabolism of thyroxine and several of its derivatives by rat kidney slices in vitro. Endocrinology. 1962 Nov;71:701–712. doi: 10.1210/endo-71-5-701. [DOI] [PubMed] [Google Scholar]
  4. Bowers C. Y., Schally A. V., Reynolds G. A., Hawley W. D. Interactions of L-thyroxine or L-triiodothyronine and thyrotropin-releasing factor on the release and synthesis of thyrotropin from the anterior pituitary gland of mice. Endocrinology. 1967 Oct;81(4):741–747. doi: 10.1210/endo-81-4-741. [DOI] [PubMed] [Google Scholar]
  5. Bowers C. Y., Schally A. V., Schalch D. S., Gual C., Kastin A. J., Folkers K. Activity and specificity of synthetic thyrotropin-releasing hormone in man. Biochem Biophys Res Commun. 1970 May 11;39(3):352–355. doi: 10.1016/0006-291x(70)90583-8. [DOI] [PubMed] [Google Scholar]
  6. Braverman L. E., Ingbar S. H., Sterling K. Conversion of thyroxine (T4) to triiodothyronine (T3) in athyreotic human subjects. J Clin Invest. 1970 May;49(5):855–864. doi: 10.1172/JCI106304. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Bray G. A., Hildreth S. Effect of propylthiouracil and methimazole on the oxygen comsumption of hypothyroid rats receiving thyroxine or triiodothyronine. Endocrinology. 1967 Nov;81(5):1018–1020. doi: 10.1210/endo-81-5-1018. [DOI] [PubMed] [Google Scholar]
  8. Chopra I. J. A radioimmunoassay for measurement of thyroxine in unextracted serum. J Clin Endocrinol Metab. 1972 Jun;34(6):938–947. doi: 10.1210/jcem-34-6-938. [DOI] [PubMed] [Google Scholar]
  9. Chopra I. J., Ho R. S., Lam R. An improved radioimmunoassay of triiodothyronine in serum: its application to clinical and physiological studies. J Lab Clin Med. 1972 Nov;80(5):729–739. [PubMed] [Google Scholar]
  10. Furth E. D., Rives K., Becker D. V. Nonthyroidal action of propylthiouracil in euthyroid, hypothyroid and hyperthyroid man. J Clin Endocrinol Metab. 1966 Mar;26(3):239–246. doi: 10.1210/jcem-26-3-239. [DOI] [PubMed] [Google Scholar]
  11. HERSHMAN J. M. EFFECT OF 5- AND 6-PROPYLTHIOURACIL ON THE METABOLISM OF L-THYROXINE IN MAN. J Clin Endocrinol Metab. 1964 Feb;24:173–179. doi: 10.1210/jcem-24-2-173. [DOI] [PubMed] [Google Scholar]
  12. HERSHMAN J. M., VAN MIDDLESWORTH L. Effect of antithyroid compounds on the deiodination of thyroxine in the rat. Endocrinology. 1962 Jul;71:94–100. doi: 10.1210/endo-71-1-94. [DOI] [PubMed] [Google Scholar]
  13. Hershman J. M., Pittman J. A., Jr Response to synthetic thyrotropin-releasing hormone in man. J Clin Endocrinol Metab. 1970 Oct;31(4):457–460. doi: 10.1210/jcem-31-4-457. [DOI] [PubMed] [Google Scholar]
  14. Hoffman W. W., Richert D. A., Westerfeld W. W. Effect of thiouracil-type drugs on the alpha-glycerophosphate dehydrogenase response to thyroxine analogs. Endocrinology. 1966 Jun;78(6):1189–1197. doi: 10.1210/endo-78-6-1189. [DOI] [PubMed] [Google Scholar]
  15. JAGIELLO G. M., McKENZIE J. M. Influence of propylthiouracil on the thyroxine-thyrotropin interplay. Endocrinology. 1960 Oct;67:451–456. doi: 10.1210/endo-67-4-451. [DOI] [PubMed] [Google Scholar]
  16. JONES S. L., VAN MIDDLESWORTH L. Normal I-131 L-thyroxine metabolism in the presence of potassium perchlorate and interrupted by propylthiouracil. Endocrinology. 1960 Dec;67:855–861. doi: 10.1210/endo-67-6-855. [DOI] [PubMed] [Google Scholar]
  17. LANG S., PREMACHANDRA B. N. Propylthiouracil and hepatic clearance of thyroid hormones. Am J Physiol. 1963 Jan;204:133–136. doi: 10.1152/ajplegacy.1963.204.1.133. [DOI] [PubMed] [Google Scholar]
  18. Mouriz J., Morreale de Escobar G., Escobar del Rey F. Evaluation of the peripheral deiodination of L-thyroxine as an index of its thyrotrophin suppressing effectiveness. Endocrinology. 1966 Aug;79(2):248–260. doi: 10.1210/endo-79-2-248. [DOI] [PubMed] [Google Scholar]
  19. Oppenheimer J. H., Schwartz H. L., Surks M. I. Propylthiouracil inhibits the conversion of L-thyroxine to L-triiodothyronine. An explanation of the antithyroxine effect of propylthiouracil and evidence supporting the concept that triiodothyronine is the active thyroid hormone. J Clin Invest. 1972 Sep;51(9):2493–2497. doi: 10.1172/JCI107063. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. RUEGAMER W. R., WESTERFELD W. W., RICHERT D. A. ALPHA-GLYCEROPHOSPHATE DEHYDROGENASE RESPONSE TO THYROXINE IN THYROIDECTOMIZED, THIOURACIL-FED AND TEMPERATURE-ADAPTED RATS. Endocrinology. 1964 Dec;75:908–916. doi: 10.1210/endo-75-6-908. [DOI] [PubMed] [Google Scholar]
  21. SLINGERLAND D. W., BURROWS B. A. Inhibition by propylthiouracil of the peripheral metabolism of radiothyroxine. J Clin Endocrinol Metab. 1962 May;22:511–517. doi: 10.1210/jcem-22-5-511. [DOI] [PubMed] [Google Scholar]
  22. STASILLI N. R., KROC R. L., EDLIN R. Selective inhibition of the calorigenic activities of certain thyroxine analogues with chronic thiouracil treatment in rats. Endocrinology. 1960 Jun;66:872–885. doi: 10.1210/endo-66-6-872. [DOI] [PubMed] [Google Scholar]
  23. Samuels H. H., Tsai J. S. Thyroid hormone action in cell culture: domonstration of nuclear receptors in intact cells and isolated nuclei. Proc Natl Acad Sci U S A. 1973 Dec;70(12):3488–3492. doi: 10.1073/pnas.70.12.3488. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Schadlow A. R., Surks M. I., Schwartz H. L., Oppenheimer J. H. Specific triiodothyronine binding sites in the anterior pituitary of the rat. Science. 1972 Jun 16;176(4040):1252–1254. doi: 10.1126/science.176.4040.1252. [DOI] [PubMed] [Google Scholar]
  25. Shenkman L., Mitsuma T., Hollander C. S. Modulation of pituitary responsiveness to thyrotropin-releasing hormone by triiodothyronine. J Clin Invest. 1973 Jan;52(1):205–209. doi: 10.1172/JCI107166. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Snyder P. J., Utiger R. D. Inhibition of thyrotropin response to thyrotropin-releasing hormone by small quantities of thyroid hormones. J Clin Invest. 1972 Aug;51(8):2077–2084. doi: 10.1172/JCI107014. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. VAN MIDDLESWORTH L., JAGIELLO G., VANDERLAAN W. P. Observations on the production of goiter in rats with propylthiouracil and on goiter prevention. Endocrinology. 1959 Feb;64(2):186–190. doi: 10.1210/endo-64-2-186. [DOI] [PubMed] [Google Scholar]
  28. VAN MIDDLESWORTH L., JONES S. L. Interference with deiodination of some thyroxine analogues in the rat. Endocrinology. 1961 Dec;69:1085–1087. doi: 10.1210/endo-69-6-1085. [DOI] [PubMed] [Google Scholar]
  29. VANARSDEL P. P., Jr, WILLIAMS R. H. Effect of propylthiouracil on degradation of I 131-labeled thyroxine and triiodothyronine. Am J Physiol. 1956 Sep;186(3):440–444. doi: 10.1152/ajplegacy.1956.186.3.440. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES